EVALUATION OF THE RESULTS OF TREATMENT OF URINARY TRACT INFECTIONS CAUSED BY URINARY STONES AT CAN THO UNIVERSITY OF MEDICINE AND PHARMACY HOSPITAL IN 2023 - 2024
Main Article Content
Abstract
Introduction: Urinary tract infections (UTIs) caused by urinary stones belong to the group of complicated UTIs, this condition today seriously affects the health sector in our country. Along with the rate of Antibiotic-resistant bacteria from the urinary tract (UTI) are increasingly increasing. Therefore, it is necessary to evaluate the treatment results in cases of urinary tract infections caused by stones. Objectives: Briefly evaluate the treatment results of urinary tract infections, surgical interventions for stones, and bacteriological characteristics in patients with urinary tract infections with urinary tract stones treated at the Urology Center of Can Tho University of Medicine and Pharmacy Hospital. Methods: Cross-sectional descriptive study of all patients diagnosed with urinary tract infections caused by urinary tract stones, with positive urine culture results, treated at the Urology Center of Can Tho University of Medicine and Pharmacy Hospital during the 2-year period from 2023 to 2024. Results: 52 cases of urinary tract infections caused by accompanying urinary tract stones and with positive culture results were recorded. The average age was 53.24 ± 11.98 (26-74) years old. The male: female ratio was 1.4:1. The main cause of urinary tract infection in this study was kidney stones, accounting for 96.2%. The rate of successful treatment of urinary tract infection was 94.2%. The initial antibiotic results were consistent with the antibiotic susceptibility test at 78.8%. The most common bacterial agent in the study was E-coli, accounting for the highest 48.1%, followed by Klebsiella pneumoniae, accounting for 13.5%. Surgical intervention for kidney stones in the study was mainly percutaneous nephrolithotomy, with C.Arm accounting for 59.6%. The most commonly used antibiotic group and the lowest resistance rate were the Carbapenem group, accounting for 55.4%, and the Aminoglycosides group, 22.5%. Conclusion: Treatment of urinary tract infection due to stones was highly effective thanks to the appropriate choice of antibiotics. However, the situation of increasingly complex bacterial spectrum, high antibiotic resistance, needs to be closely monitored.
Article Details
Keywords
urinary tract infection, urinary tract stones, antibiotics
References

2. Vera-Leiva AB-LC, Carrasco-Anabalón SLC, AguayoReyes A, Domínguez M, et al (2017). KPC: Klebsiella pneumoniae carbapenemase, main carbapenemase in Enterobacteriaceae. Rev Chilena Infectol, 34(5):476-484.

3. Anthony JS, Rischard SM, David JK (2016), ‘’ Infections of the Urinary tract ‘’,Cambell-Waslsh ‘ s Urology, 11 th edition, vol1, Elsevier- Saunder, pp 237,303.

4. Hội Tiết niệu Thận học Việt Nam (2020), “Hướng dẫn điều trị nhiễm khuẩn đường tiết niệu ở Việt Nam”. VUNA

5. Bộ Y tế. HƯỚNG DẪN CHẨN ĐOÁN VÀ ĐIỀU TRỊ MỘT SỐ BỆNH VỀ THẬN - TIẾT NIỆU. 2015.

6. Bộ Y tế. Việt Nam hiện tỷ lệ người mắc bệnh đái tháo đường đang gia tăng nhanh 2023.

7. Vũ Thị Thơm (2018), “Nghiên cứu tình hình, lâm sàng, cận lâm sàng và đánh giá kết quả điều trị ở bệnh nhân Nhiễm khuẩn đường Tiết niệu tại Bệnh viện Đa khoa Trung ương Cần Thơ năm 2017-2018”, Luận văn Thạc sĩ Y học, Đại học Y Dược Cần Thơ.

8. Lê Đình Khánh, Lê Đình Đạm, Nguyễn Khoa Hùng và cs. (2018), "Tình hình nhiễm khuẩn đường tiết niệu tại khoa ngoại tiết niệu Bệnh viện Trường Đại học Y Dược Huế", Tạp chí Y Dược học - Trường Đại học Y Dược Huế. 8 (3), 100-108.

9 .Trần Hữu Toàn (2020). Đánh giá kết quả chẩn đoán và điều trị nhiễm khuẩn huyết và choáng nhiễm khuẩn ở bệnh nhân bế tắc đường tiết niệu trên tại bệnh viện Chợ Rẫy. Luận văn tốt nghiệp Bác sĩ Nội trú.

10. Jean SS, Hsueh PR (2017). Distribution of ESBLs, AmpC β-lactamases and carbapenemases among Enterobacteriaceae isolates causing intra- abdominal and urinary tract infections in the Asia- Pacific region during 2008-14: results from the Study for Monitoring Antimicrobial Resistance Trends (SMART). J Antimicrob Chemother, 72(1):166-171.
